Irreversible cell growth arrest, a process termed cellular senescence, is emerging as an intrinsic tumor suppressive mechanism. Oncogene-induced senescence is thought to be invariably preceded by hyperproliferation, aberrant replication, and activation of a DNA damage checkpoint response (DDR), rendering therapeutic enhancement of this process unsuitable for cancer treatment. We previously demonstrated in a mouse model of prostate cancer that inactivation of the tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (Pten) elicits a senescence response that opposes tumorigenesis. Here, we show that Pten-loss-induced cellular senescence (PICS) represents a senescence response that is distinct from oncogene-induced senescence and can be targeted for cancer therapy. Using mouse embryonic fibroblasts, we determined that PICS occurs rapidly after Pten inactivation, in the absence of cellular proliferation and DDR. Further, we found that PICS is associated with enhanced p53 translation. Consistent with these data, we showed that in mice p53-stabilizing drugs potentiated PICS and its tumor suppressive potential. Importantly, we demonstrated that pharmacological inhibition of PTEN drives senescence and inhibits tumorigenesis in vivo in a human xenograft model of prostate cancer. Taken together, our data identify a type of cellular senescence that can be triggered in nonproliferating cells in the absence of DNA damage, which we believe will be useful for developing a "pro-senescence" approach for cancer prevention and therapy.

A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis / Alimonti, A.; Nardella, C.; Chen, Z.; Clohessy, J. G.; Carracedo, A.; Trotman, L. C.; Cheng, K.; Varmeh, S.; Kozma, S. C.; Thomas, G.; Rosivatz, E.; Woscholski, R.; Cognetti, F.; Scher, H. I.; Pandolfi, P. P.. - In: THE JOURNAL OF CLINICAL INVESTIGATION. - ISSN 0021-9738. - 120:3(2010), pp. 681-693. [10.1172/JCI40535]

A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis

Chen Z.;Thomas G.;Cognetti F.;
2010

Abstract

Irreversible cell growth arrest, a process termed cellular senescence, is emerging as an intrinsic tumor suppressive mechanism. Oncogene-induced senescence is thought to be invariably preceded by hyperproliferation, aberrant replication, and activation of a DNA damage checkpoint response (DDR), rendering therapeutic enhancement of this process unsuitable for cancer treatment. We previously demonstrated in a mouse model of prostate cancer that inactivation of the tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (Pten) elicits a senescence response that opposes tumorigenesis. Here, we show that Pten-loss-induced cellular senescence (PICS) represents a senescence response that is distinct from oncogene-induced senescence and can be targeted for cancer therapy. Using mouse embryonic fibroblasts, we determined that PICS occurs rapidly after Pten inactivation, in the absence of cellular proliferation and DDR. Further, we found that PICS is associated with enhanced p53 translation. Consistent with these data, we showed that in mice p53-stabilizing drugs potentiated PICS and its tumor suppressive potential. Importantly, we demonstrated that pharmacological inhibition of PTEN drives senescence and inhibits tumorigenesis in vivo in a human xenograft model of prostate cancer. Taken together, our data identify a type of cellular senescence that can be triggered in nonproliferating cells in the absence of DNA damage, which we believe will be useful for developing a "pro-senescence" approach for cancer prevention and therapy.
2010
animals; cell Line, tumor; DNA damage; disease models, animal; embryo, mammalian; fibroblasts; humans; male; mice; Mice, Knockout; Neoplasm Transplantation; PTEN phosphohydrolase; prostatic neoplasms; protein biosynthesis; transplantation, heterologous; tumor suppressor protein p53; cell proliferation; cellular senescence; gene rxpression regulation; neoplastic
01 Pubblicazione su rivista::01a Articolo in rivista
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis / Alimonti, A.; Nardella, C.; Chen, Z.; Clohessy, J. G.; Carracedo, A.; Trotman, L. C.; Cheng, K.; Varmeh, S.; Kozma, S. C.; Thomas, G.; Rosivatz, E.; Woscholski, R.; Cognetti, F.; Scher, H. I.; Pandolfi, P. P.. - In: THE JOURNAL OF CLINICAL INVESTIGATION. - ISSN 0021-9738. - 120:3(2010), pp. 681-693. [10.1172/JCI40535]
File allegati a questo prodotto
File Dimensione Formato  
Alimonti_A-novel_2019.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 4.59 MB
Formato Adobe PDF
4.59 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1310599
Citazioni
  • ???jsp.display-item.citation.pmc??? 159
  • Scopus 269
  • ???jsp.display-item.citation.isi??? 251
social impact